Validation of an FFQ for evaluation of EPA and DHA intake

Public Health Nutrition

Volumn 12, Issue 10, 2009, Pages 1783-1790

  Lucas, Michel ^a   Asselin, Geneviéve ^a   Mérette, Chantal ^a   Poulin, Marie Josée ^a   Dodin, Sylvie ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

DHA; EPA; FFQ; Fish; Marine food products; N 3 Fatty acids; Red blood cells; Seafood

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ANIMAL; ARTICLE; BLOOD; CANADA; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ERYTHROCYTE; FEMALE; HUMAN; MIDDLE AGED; NONPARAMETRIC TEST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SEA FOOD; STANDARD; VALIDATION STUDY;

ANIMALS; CROSS-SECTIONAL STUDIES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FEMALE; HUMANS; MIDDLE AGED; QUEBEC; QUESTIONNAIRES; REGRESSION ANALYSIS; SEAFOOD; STATISTICS, NONPARAMETRIC;

EID: 75149143517     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980008004333     Document Type: Article

References (45)

1. Kris-Etherton PM, Harris WS & Appel LJ (2002) AHA Scientific Statement. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747-2757.
2. Freeman MP, Hibbeln JR, Wisner KL et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954-1967.
3. Calder PC (2006) n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 6 Suppl., 1505S-1519S.
4. Mozaffarian D & Rimm EB (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296, 1885-1899.
5. Arab L (2003) Biomarkers of fat and fatty acid intake. J Nutr 133, Suppl. 3, 925S-932S.
6. Bates CJ & Thurnham DI (1997) Biochemical markers of nutrient intake. In Design Concepts in Nutritional Epidemiology, 2nd ed., pp. 170-240 [BM Margetts and M Nelson, editors]. New York: Oxford University Press.
7. Willett WC (editor) (1998) Nutritional Epidemiology, 2nd ed., p. 414. New York: Oxford University Press.
8. Cantwell MM (2000) Assessment of individual fatty acid intake. Proc Nutr Soc 59, 187-191.
9. Hebert JR, Ma Y, Clemow L, Ockene IS, Saperia G, Stanek EJ 3rd, Mérriam PA & Ockene JK (1997) Gender differences in social desirability and social approval bias in dietary selfreport. Am J Epidemiol 146, 1046-1055.
10. Holman RT (1998) The slow discovery of the importance of omega 3 essential fatty acids in human health. J Nutr 128, 2 Suppl., 427S-433S.
11. Plourde M & Cunnane S (2007) Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619-634.
12. Sun Q, Ma J, Campos H, Hankinson SE & Hu FB (2007) Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86, 74-81.
13. Kobayashi M, Sasaki S, Kawabata T, Hasegawa K & Tsugane S (2003) Validity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I to assess fatty acid intake: comparison with dietary records and serum phospholipid level. J Epidemiol 13, 1 Suppl., S64-S81.
14. Barberger-Gateau P, Jutand MA, Letenneur L, Larrieu S, Tavernier B & Berr C; 3C Study Group (2005) Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur J Clin Nutr 59, 817-825.
15. Hjartaker A, Lund E & Bjerve KS (1997) Serum phospholipid fatty acid composition and habitual intake of marine foods registered by a semi-quantitative food frequency questionnaire. Eur J Clin Nutr 51, 736-742.
16. Woods RK, Stoney RM, Ireland PD, Bailey MJ, Raven JM, Thien FC, Walters EH & Abramson MJ (2002) A valid food frequency questionnaire for measuring dietary fish intake. Asia Pac J Clin Nutr 11, 56-61.
17. Mina K, Fritschi L & Knuiman M (2007) A valid semiquantitative food frequency questionnaire to measure fish consumption. Eur J Clin Nutr 61, 1023-1031.
18. Hodge AM, Simpson JA, Gibson RA, Sinclair AJ, Makrides M, O'Dea K, English DR & Giles GG (2007) Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutr Metab Cardiovasc Dis 17, 415-426.
19. Baylin A, Kim MK, Donovan-Palmer A, Siles X, Dougherty L, Tocco P & Campos H (2005) Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am J Epidemiol 162, 373-381.
20. Broadfield E, McKeever T, Fogarty A & Britton J (2003) Measuring dietary fatty acid intake: validation of a foodfrequency questionnaire against 7 d weighed records. Br J Nutr 90, 215-220.
21. Kobayashi M, Sasaki S, Kawabata T, Hasegawa K, Akabane M & Tsugane S (2001) Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged Japanese men. Eur J Clin Nutr 55, 643-650.
22. Kuriki K, Nagaya T, Tokudome Y et al. (2003) Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J Nutr 133, 3643-3650.
23. Lucas M, Asselin G, Mérette C, Poulin M-J & Dodin S (2008) Ethyl-eicosapentaenoic acid in the treatment of psychological distress and depressive symptoms among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr (In the Press).
24. Dupuy H (1984) The Psychological General Well-Being (PGWB) Index. In Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies, pp. 170-183 [NK Wenger, ME Mattson, CD Furber et al., editors]. New York: Le Jacq Publishing Inc.
25. Ross BM (2007) Omega-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism. Med Hypotheses 68, 515-524.
26. Horrobin DF & Bennett CN (1999) Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 60, 217-234.
27. Health Canada (2005) Canadian Nutrient File. http:// www.hc-sc.gc.ca/fn- an/nutrition/fiche-nutri-data/index-e. html (accessed October 2006).
28. Shaikh NA & Downar E (1981) Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ Res 49, 316-325.
29. Lepage G & Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27, 114-120.
30. Sprecher H (2000) Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 1486, 219-231.
31. Harris WS & Von Schacky C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39, 212-220.
32. Babyak MA (2004) What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression- type models. Psychosom Med 66, 411-421.
33. Godley PA, Campbell MK, Miller C, Gallagher P, Martinson FE, Mohler JL & Sandler RS (1996) Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 5, 115-119.
34. Parra MS, Schnaas L, Meydani M, Perroni E, Martinez S & Romieu I (2002) Erythrocyte cell membrane phospholipid levels compared against reported dietary intakes of polyunsaturated fatty acids in pregnant Mexican women. Public Health Nutr 5, 931-937.
35. Patch C, Murphy K, Mansour J et al. (2004) Erythrocyte biomarker-based validation of a diet history method used in a dietary intervention trial. Asia Pac J Clin Nutr 13, Suppl., S60.
36. Fuhrman BJ, Barba M, Krogh V et al. (2006) Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab 50, 95-102.
37. Cao J, Schwichtenberg KA, Hanson NQ & Tsai MY (2006) Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 52, 2265-2272.
38. Arterburn LM, Hall EB & Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, 6 Suppl., 1467S-1476S.
39. Katan MB, Deslypere JP, Van Birgelen APJM, Penders M & Zegwaard M (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38, 2012-2022.
40. Brown AJ, Pang E & Roberts DCK (1991) Erythrocyte eicosapentaenoic acid versus docosahexaenoic acid as a marker for fish and fish oil consumption. Prostaglandins Leukot Essent Fatty Acids 44, 103-106.
41. Brown AJ, Pang E & Roberts DC (1991) Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr 54, 668-673.
42. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB & Borkon AM (2004) Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 110, 1645-1649.
43. Burdge G (2004) a-Linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 7, 137-144.
44. Anderson LF, Solvoll K & Drevon CA (1996) Verylong- chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. Am J Clin Nutr 64, 305-311.
45. Potischman N (2003) Biologic and methodologic issues for nutritional biomarkers. J Nutr 133, Suppl. 3, 875S-880S.